Okanagan Clinical Trials has been conducting clinical research since 1992 under the direction of CEO Dr. Paul Latimer and primary investigator Dr. Sally Godsell. Recognizing the growing need for Alzheimer’s clinical research, the team recruited Dr. Kim Christie to spearhead a research initiative that focuses on Alzheimer’s disease. “With a personal connection to the disease and a background in neuroscience, I’m driven to be a part of the research that will one day reveal a medication that either prevents Alzheimer’s or slows its progression.” (Dr. Kim Christie) The research team at Okanagan Clinical Trials are extremely dedicated to their Alzheimer’s patients and caregivers and include Patti Roberts, CCRP, Kathy Ross, CCRP, Carol Fazekas, BA, CCRP, Wendy Zabel and Lyndall Cay.
DR. PAUL LATIMERPrincipal investigator
DR. KIM CHRISTIE, PhDDirector of Research
Be a citizen scientist and help preserve
millions of memories for generations to come.
Thousands of research volunteers are needed now.JOIN NOW